mannitol has been researched along with nifedipine in 27 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (11.11) | 18.7374 |
1990's | 5 (18.52) | 18.2507 |
2000's | 10 (37.04) | 29.6817 |
2010's | 9 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Duffy, EM; Jorgensen, WL | 1 |
Huang, L; Humphreys, JE; Morgan, JB; Polli, JW; Serabjit-Singh, CS; Webster, LO; Wring, SA | 1 |
Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Greer, MA; Greer, SE; McAdams, S; Sato, N; Wang, XB | 1 |
Camilión De Hurtado, MC; Gende, OA | 1 |
Bratell, S; Folmerz, P; Hansson, R; Jonsson, O; Lundstam, S; Pettersson, S; Rippe, B; Scherstén, T | 1 |
Allsopp, D; Bailey, PJ; Higgins, TJ | 1 |
Ma, JK; Malanga, CJ; Pan, WF; Rojanasakul, Y; Toledo-Velasquez, D; Wang, LY | 1 |
Aoki, T; Koshita, M; Nihonyanagi, K; Oba, T; Yamaguchi, M | 1 |
Ausina, P; Candenas, L; Martin, JD; Pinto, FM; Savineau, JP | 1 |
Crespi, CL; Davitt, CM; Hu, M; Huang, SM; Li, Y; Penman, BW; Thummel, K | 1 |
Higo, A; Katsura, M; Mohri, Y; Ohkuma, S; Shirotani, K; Shuto, K; Takesue, M; Tarumi, C | 1 |
Ho, HO; Lin, YK | 1 |
Bele, M; Obreza, A; Srcic, S; Zajc, N | 1 |
Ayazifar, M; Murphy, MA | 1 |
Abbate, M; Ferlazzo, E; Granata, F; Mazzù, I; Musolino, R; Narbone, MC | 1 |
Sun, Y; Tao, J; Yu, L; Zhang, GG | 1 |
Athersuch, TJ; Cavill, R; Ebbels, TM; Ellis, JK; Jennings, P; Keun, HC; McMorrow, T; Radford, R; Ryan, MP; Slattery, C | 1 |
de Villiers, MM; Derdour, L; Huang, J; Hussain, MA; Qian, F; Yu, L; Zhang, SW | 1 |
Ebrahimi, A; Langrish, T; Saffari, M | 1 |
Arakawa, H; Hatano, Y; Ichiba, K; Idota, Y; Kamioka, H; Kanagawa, M; Morimoto, K; Ogihara, T; Ohmachi, T; Tomono, T; Yano, K | 1 |
1 review(s) available for mannitol and nifedipine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
26 other study(ies) available for mannitol and nifedipine
Article | Year |
---|---|
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
Rational use of in vitro P-glycoprotein assays in drug discovery.
Topics: Adenosine Triphosphatases; Animals; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cells, Cultured; Chromatography, Liquid; Enzyme Inhibitors; Fluoresceins; Fluorescent Dyes; Humans; Mass Spectrometry; Pharmacology; Spodoptera | 2001 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Evidence that ethanol induces prolactin secretion in GH4C1 cells by producing cell swelling with resultant calcium influx.
Topics: Animals; Calcium; Cell Line; Ethanol; Kinetics; Mannitol; Nifedipine; Osmolar Concentration; Pituitary Neoplasms; Prolactin | 1990 |
Chronotropic response to hyperosmotic solutions of isolated rat atria.
Topics: Alcohols; Animals; Calcium; Ethylene Glycols; Glycerol; Heart Rate; In Vitro Techniques; Mannitol; Nifedipine; Osmotic Pressure; Rats; Sucrose | 1987 |
Effects of oxygen free radical scavengers, xanthine oxidase inhibition and calcium entry-blockers on leakage of albumin after ischaemia. An experimental study in rabbit kidneys.
Topics: Allopurinol; Animals; Calcium Channel Blockers; Capillary Permeability; Catalase; Felodipine; Free Radicals; Ischemia; Kidney; Mannitol; Nifedipine; Nitrendipine; Oxygen; Rabbits; Serum Albumin, Radio-Iodinated; Superoxide Dismutase; Xanthine Oxidase | 1988 |
The effect of extracellular calcium concentration and Ca-antagonist drugs on enzyme release and lactate production by anoxic heart cell cultures.
Topics: Animals; Calcium; Cells, Cultured; Glucose; Heart; Hypoxia; L-Lactate Dehydrogenase; Lactates; Mannitol; Myocardium; Nifedipine; Rats; Verapamil | 1980 |
Alveolar permeability enhancement by oleic acid and related fatty acids: evidence for a calcium-dependent mechanism.
Topics: Animals; Calcium; Cell Membrane Permeability; Cell Survival; Fatty Acids; Fura-2; Male; Mannitol; Microscopy, Fluorescence; Nifedipine; Oleic Acid; Oleic Acids; Progesterone; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley | 1994 |
Muscle contraction and inward current induced by silver and effect of Ca2+ channel blockers.
Topics: Animals; Cadmium; Calcium Channel Blockers; Calcium Channels; Cations, Divalent; In Vitro Techniques; Mannitol; Membrane Potentials; Muscle Contraction; Muscles; Nifedipine; Rana catesbeiana; Ranidae; Silver; Time Factors | 1993 |
Ca(2+)-independent contraction induced by hyperosmolar K(+)-rich solutions in rat uterus.
Topics: Animals; Calcium; Enzyme Inhibitors; Female; In Vitro Techniques; Mannitol; Muscle Contraction; Nifedipine; Osmolar Concentration; Protein Kinase Inhibitors; Rats; Rats, Wistar; Sucrose; Uterus | 1996 |
Transport and metabolic characterization of Caco-2 cells expressing CYP3A4 and CYP3A4 plus oxidoreductase.
Topics: Anticoagulants; Antineoplastic Agents, Hormonal; Biological Transport; Caco-2 Cells; Calcium Channel Blockers; Carcinogens; Cell Division; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Diuretics, Osmotic; GABA Modulators; Gene Expression Regulation, Enzymologic; Genetic Vectors; Humans; Indoles; Mammary Tumor Virus, Mouse; Mannitol; Microscopy, Electron; Microsomes; Midazolam; Mixed Function Oxygenases; Nifedipine; Oxidoreductases; Propranolol; Pyridines; Sympatholytics; Testosterone; Tetradecanoylphorbol Acetate; Transfection; Tritium; Warfarin | 1999 |
Suppression of Ca2+ influx through L-type voltage-dependent calcium channels by hydroxyl radical in mouse cerebral cortical neurons.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Calcium Signaling; Cells, Cultured; Cerebral Cortex; Deferoxamine; Ferrous Compounds; Free Radical Scavengers; Hydrogen Peroxide; Hydroxyl Radical; Ion Channel Gating; Ion Transport; Iron Chelating Agents; Mannitol; Mice; Nerve Tissue Proteins; Neurons; Nifedipine; omega-Agatoxin IVA; omega-Conotoxin GVIA; Potassium Chloride; Thiourea | 2001 |
Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice.
Topics: Administration, Oral; Capsules; Delayed-Action Preparations; Drug Combinations; Drug Delivery Systems; Drug Stability; Hypromellose Derivatives; Mannitol; Methylcellulose; Nifedipine; Osmolar Concentration; Osmotic Pressure; Permeability; Pharmaceutic Aids; Pharmaceutical Preparations; Polymers; Sodium Dodecyl Sulfate; Solubility; Suspensions; Technology, Pharmaceutical; Viscosity | 2003 |
Physical properties and dissolution behaviour of nifedipine/mannitol solid dispersions prepared by hot melt method.
Topics: Calcium Channel Blockers; Chemistry, Pharmaceutical; Crystallization; Drug Carriers; Drug Compounding; Drug Stability; Hot Temperature; Magnetic Resonance Spectroscopy; Mannitol; Microscopy, Electron, Scanning; Nifedipine; Solubility; Spectroscopy, Fourier Transform Infrared; Technology, Pharmaceutical | 2005 |
Permanent visual deficits secondary to the HELLP syndrome.
Topics: Adult; Blood Pressure; Brain Infarction; Drug Therapy, Combination; Eclampsia; Female; Furosemide; HELLP Syndrome; Hemianopsia; Humans; Intracranial Hemorrhages; Labetalol; Magnetic Resonance Imaging; Mannitol; Nifedipine; Occipital Lobe; Pregnancy; Retinal Hemorrhage; Visual Acuity | 2005 |
PRES: posterior or potentially reversible encephalopathy syndrome?
Topics: Adult; Anti-Inflammatory Agents; Anticonvulsants; Antihypertensive Agents; Brain; Brain Diseases; Clonidine; Dexamethasone; Diazepam; Diuretics, Osmotic; Eclampsia; Female; Humans; Magnesium Sulfate; Magnetic Resonance Imaging; Mannitol; Nifedipine; Pregnancy; Seizures | 2006 |
Solubility of small-molecule crystals in polymers: D-mannitol in PVP, indomethacin in PVP/VA, and nifedipine in PVP/VA.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Crystallization; Indomethacin; Kinetics; Mannitol; Nifedipine; Povidone; Pyrrolidines; Reproducibility of Results; Solubility; Solvents; Technology, Pharmaceutical; Transition Temperature; Vinyl Compounds; Viscosity | 2009 |
Metabolic response to low-level toxicant exposure in a novel renal tubule epithelial cell system.
Topics: Bromates; Cell Line; Diclofenac; Environmental Pollutants; Epithelial Cells; Humans; Kidney Tubules; Magnetic Resonance Spectroscopy; Mannitol; Methylurea Compounds; Microscopy, Fluorescence; Nifedipine; Ochratoxins; Principal Component Analysis; Toxicity Tests | 2011 |
A method to evaluate the effect of contact with excipients on the surface crystallization of amorphous drugs.
Topics: Cellulose; Chemistry, Pharmaceutical; Crystallization; Excipients; Humidity; Indomethacin; Kinetics; Lactose; Mannitol; Nifedipine; Stearic Acids; Surface Properties; Tablets; Technology, Pharmaceutical; Water | 2014 |
A novel formulation for solubility and content uniformity enhancement of poorly water-soluble drugs using highly-porous mannitol.
Topics: Adsorption; Chemistry, Pharmaceutical; Drug Liberation; Excipients; Indomethacin; Mannitol; Nifedipine; Porosity; Solubility | 2016 |
Interaction of Peptide Transporter 1 With D-Glucose and L-Glutamic Acid; Possible Involvement of Taste Receptors.
Topics: Animals; Calcium Channel Blockers; Cephalexin; Glucose; Glutamic Acid; Intestinal Absorption; Jejunum; Male; Mannitol; Membranes; Nifedipine; Peptide Transporter 1; Protein Transport; Rats; Rats, Wistar; Sensory Receptor Cells; Symporters; Taste Buds | 2016 |